title: The year in cardiology: heart failure 2014.
authors.affiliation: Department of Cardiology, AB31, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9713 GZ, The Netherlands a.a.voors@umcg.nl.
authors.forename: Adriaan A
authors.initials: AA
authors.lastname: Voors
authors.affiliation: Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland.
authors.forename: Frank
authors.initials: F
authors.lastname: Ruschitzka
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D058406:Cardiac Resynchronization Therapy; D002316:Cardiotonic Agents / Q000627:therapeutic use; D057890:Epigenomics / Q000639:trends; D005544:Forecasting; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D012065:Relaxin / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects; D013148:Spironolactone / Q000627:therapeutic use; D013318:Stroke Volume / Q000502:physiology; D017216:Telemedicine / Q000706:statistics & numerical data; D055536:Vagus Nerve Stimulation / Q000706:statistics & numerical data
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D000451:Mineralocorticoid Receptor Antagonists; D011994:Recombinant Proteins; C577649:serelaxin protein, human; D013148:Spironolactone; D012065:Relaxin; D007501:Iron